INHIBITION OF EPOXIDE HYDROLASE BY ANTICONVULSANTS AND RISK OF TERATOGENICITY
- 1 March 1989
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 333 (8638) , 610-611
- https://doi.org/10.1016/s0140-6736(89)91630-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: In vitro/in vivo correlationClinical Pharmacology & Therapeutics, 1989
- Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk FactorsEpilepsia, 1988
- Valpromide but Not Sodium Hydrogen Divalproate Inhibits Epoxide Hydrolase in Human LiverBasic & Clinical Pharmacology & Toxicology, 1987
- Sodium Valproate and Valpromide: Differential Interactions with Carbamazepine in Epileptic PatientsEpilepsia, 1986
- Valpromide inhibits human epoxide hydrolase.British Journal of Clinical Pharmacology, 1986
- VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITYThe Lancet, 1985
- POSSIBLE HAZARD OF VALPROMIDE-CARBAMAZEPINE COMBINATION THERAPY IN EPILEPSYThe Lancet, 1984
- Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine)Epilepsia, 1984